Skip to main content

Translational Drug Development for Pediatric CNS Disorders

Publication ,  Conference
Potter, W; Grabb, M; Pandina, G; Jeste, S; Di Martino, A; Gur, R; Hornik, C; Mantua, V; Taylor-Zapata, P; Umbricht, D
Published in: NEUROPSYCHOPHARMACOLOGY
2021

Duke Scholars

Published In

NEUROPSYCHOPHARMACOLOGY

EISSN

1740-634X

ISSN

0893-133X

Publication Date

2021

Volume

46

Issue

SUPPL 1

Start / End Page

6 / 6

Related Subject Headings

  • Psychiatry
  • 5202 Biological psychology
  • 3209 Neurosciences
  • 17 Psychology and Cognitive Sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Potter, W., Grabb, M., Pandina, G., Jeste, S., Di Martino, A., Gur, R., … Umbricht, D. (2021). Translational Drug Development for Pediatric CNS Disorders. In NEUROPSYCHOPHARMACOLOGY (Vol. 46, pp. 6–6).
Potter, William, Meg Grabb, Gahan Pandina, Shafali Jeste, Adriana Di Martino, Raquel Gur, Christoph Hornik, Valentina Mantua, Perdita Taylor-Zapata, and Daniel Umbricht. “Translational Drug Development for Pediatric CNS Disorders.” In NEUROPSYCHOPHARMACOLOGY, 46:6–6, 2021.
Potter W, Grabb M, Pandina G, Jeste S, Di Martino A, Gur R, et al. Translational Drug Development for Pediatric CNS Disorders. In: NEUROPSYCHOPHARMACOLOGY. 2021. p. 6–6.
Potter, William, et al. “Translational Drug Development for Pediatric CNS Disorders.” NEUROPSYCHOPHARMACOLOGY, vol. 46, no. SUPPL 1, 2021, pp. 6–6.
Potter W, Grabb M, Pandina G, Jeste S, Di Martino A, Gur R, Hornik C, Mantua V, Taylor-Zapata P, Umbricht D. Translational Drug Development for Pediatric CNS Disorders. NEUROPSYCHOPHARMACOLOGY. 2021. p. 6–6.

Published In

NEUROPSYCHOPHARMACOLOGY

EISSN

1740-634X

ISSN

0893-133X

Publication Date

2021

Volume

46

Issue

SUPPL 1

Start / End Page

6 / 6

Related Subject Headings

  • Psychiatry
  • 5202 Biological psychology
  • 3209 Neurosciences
  • 17 Psychology and Cognitive Sciences
  • 11 Medical and Health Sciences